Leveraging cutting-edge AI and advanced optoelectronic imaging technologies, this laboratory seeks to create a collaborative innovation platform for blinding eye diseases that integrates technological innovation, equipment development, and translational medicine capabilities. Through "medicine-research-industry" partnerships for coordinated innovation, the laboratory aspires to build an R&D platform for ophthalmic drugs and devices.